These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

653 related items for PubMed ID: 27273744

  • 1. The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients.
    Khanuntong S, Kuptawintu P, Upaisilpsathaporn K, Poolchareon A, Bunworasate U, Hirankarn N.
    HLA; 2016 Jun; 87(6):422-31. PubMed ID: 27273744
    [Abstract] [Full Text] [Related]

  • 2. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.
    Hsu KC, Keever-Taylor CA, Wilton A, Pinto C, Heller G, Arkun K, O'Reilly RJ, Horowitz MM, Dupont B.
    Blood; 2005 Jun 15; 105(12):4878-84. PubMed ID: 15731175
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of killer cell immunoglobulin-like receptor genotype on outcome of hematopoietic stem cell transplantation from matched sibling.
    Elfishawi SM, Mossallam GI, El-Fattah RA, El-Haddad A, Kamel AM.
    Hum Immunol; 2017 Nov 15; 78(11-12):684-691. PubMed ID: 28993188
    [Abstract] [Full Text] [Related]

  • 7. The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.
    Clausen J, Kircher B, Auberger J, Schumacher P, Ulmer H, Hetzenauer G, Wolf D, Gastl G, Nachbaur D.
    Biol Blood Marrow Transplant; 2010 Feb 15; 16(2):273-80. PubMed ID: 19857587
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide.
    Shimoni A, Labopin M, Lorentino F, Van Lint MT, Koc Y, Gülbas Z, Tischer J, Bruno B, Blaise D, Pioltelli P, Afanasyev B, Ciceri F, Mohty M, Nagler A.
    Leukemia; 2019 Jan 15; 33(1):230-239. PubMed ID: 29907809
    [Abstract] [Full Text] [Related]

  • 10. The impact of recipient HLA-Cw and donor killer immunoglobulin-like receptor genotyping on the outcome of patients receiving HLA-matched sibling donor hematopoietic stem cell transplantation for myeloid malignancies.
    Wang H, He Y, Zhai WJ, Wang M, Zhou Z, Zhao YX, Feng SZ, Han MZ.
    Swiss Med Wkly; 2013 Jan 15; 143():w13717. PubMed ID: 23299929
    [Abstract] [Full Text] [Related]

  • 11. Mesenchymal stem cells enhance the impact of KIR receptor-ligand mismatching on acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia but not in those with acute lymphocytic leukemia.
    Zhang Y, Zheng H, Ren J, Luo X, Zheng Z, Zheng J, Zheng X, Chen Y, Chen Z, Hu J, Yang T.
    Hematol Oncol; 2021 Aug 15; 39(3):380-389. PubMed ID: 33848027
    [Abstract] [Full Text] [Related]

  • 12. Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation.
    McQueen KL, Dorighi KM, Guethlein LA, Wong R, Sanjanwala B, Parham P.
    Hum Immunol; 2007 May 15; 68(5):309-23. PubMed ID: 17462498
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The impact of donor and recipient KIR genes and KIR ligands on the occurrence of acute graft-versus-host disease and graft survival after HLA-identical sibling hematopoietic stem cell transplantation.
    Hoseinian SA, Jafari D, Mahmoodi M, Alimoghaddam K, Ostadali M, Talebzadeh Bonakdar A, Foma AM, Yekaninejad MS, Amirzargar AA.
    Turk J Med Sci; 2018 Aug 16; 48(4):794-804. PubMed ID: 30119155
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Analysis of KIR genes in HLA-identical sibling hematopoietic stem cell transplantation in Thai patients with leukemia.
    Wongwuttisaroj N, Vejbaesya S, Chongkolwatana V, Issaragrisil S.
    J Med Assoc Thai; 2012 Oct 16; 95(10):1261-5. PubMed ID: 23193738
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K, Nishida T, Asano-Mori Y, Oshima K, Ohashi K, Mori T, Kanamori H, Miyamura K, Kato C, Kobayashi N, Uchida N, Nakamae H, Ichinohe T, Morishima Y, Suzuki R, Yamaguchi T, Fukuda T.
    Biol Blood Marrow Transplant; 2015 Nov 16; 21(11):2008-16. PubMed ID: 26211985
    [Abstract] [Full Text] [Related]

  • 20. Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.
    Cooley S, Trachtenberg E, Bergemann TL, Saeteurn K, Klein J, Le CT, Marsh SG, Guethlein LA, Parham P, Miller JS, Weisdorf DJ.
    Blood; 2009 Jan 15; 113(3):726-32. PubMed ID: 18945962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.